Laquinimod in Participants With Systemic Lupus Erythematosus Active Lupus Nephritis

- Lupus Nephritis
- Completed

Study Title: Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis

Teva Identifier: LN-LAQ-201 | 2010-018329-20

ClinicalTrials.gov Identifier: NCT01085097

Study Status: Completed

Trial Condition(s): Lupus Nephritis

Interventions: Drug: laquinimod | Drug: Mycophenolate Mofetil | Drug: prednisolone/prednisone | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult, Older Adult

Age Range: 18 Years to 75 Years

Trial Duration: 07/01/2010 - 12/01/2012

Phase: Phase 2

Study Type

Interventional